Impact of Leflunomide Versus Biologic Agents on the Costs of Care for Rheumatoid Arthritis in a Managed Care Population

Publication

Article

May 1, 2002

Supplements and Featured Publications

Cost and Utilization Analysis for Rheumatoid Arthritis Treatments: An Update for Managed Care

Volume8

Issue 7 Suppl

Author(s):

Download PDF: Impact of Leflunomide Versus Biologic Agents on the Costs of Care for Rheumatoid Arthritis in a Managed Care Population

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

2 Commerce Drive
Suite 100
Cranbury, NJ 08512